{
    "nctId": "NCT04579107",
    "briefTitle": "KARMA Kontrast Evaluating Contrast Enhanced Mammography in Early Detection of Breast Cancer",
    "officialTitle": "KARMA Kontrast - a Controlled Clinical Trial Evaluating Contrast Enhanced Mammography in Early Detection of Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 420,
    "primaryOutcomeMeasure": "Sensitivity of Contrast Enhanced Mammography",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* Age: \\>25 - \\<85 years\n* Recalled after Mx screening based on abnormal mammographic findings or refered for breast cancer related symtoms\n* The woman has read, understood and signed the Informed Consent Form (ICF)\n\nExclusion Criteria:\n\n* Previous breast cancer\n* A breast biopsy performed within 6 weeks preceding the study\n* Recent exposure (during the last week) to iodine contrast media.\n* Pregnancy\n* Current breast feeding\n* Diagnosed with a pheochromocytoma or a paraganglioma\n* Diagnosed with myeloma or other malignant plasma cell disease\n* Diagnosed with myasthenia gravis\n* A renal failure or kidney disorder with increased risk for developing renal failure (single kidney or kidney transplanted)\n* Diabetes (other than dietary treated)\n* Heart failure or liver failure\n* Intake of potentially nephrotoxic substances (daily intake of NSAID, nephrotoxic antibiotics or nephrotoxic chemotherapy)\n* Iodine contrast allergy\n* Uncontrolled thyrotoxicosis\n* A history of severe allergy\n* Subjects unable to read, understand and execute written informed consent\n* Any medical aspect that, according to the investigator, could jeopardize the health of the participant",
    "sex": "FEMALE",
    "minimumAge": "25 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}